Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanez

Showing results (841-850 of 916) with videos related to

Pageof 92
Sort By:
Molecular Therapy. Methods & Clinical Development|March 4, 2025
Generation and GMP scale-up of human CAR-T cells using non-viral <i>Sleeping Beauty</i> transposons for B cell malignancesBegoña Diez, Cristina Calviño, María Fernández-García, et al.
Frontiers in Medicine|July 21, 2022
Prevalence of Chronic Infection by Hepatitis C Virus in Asymptomatic Population With Risk Factors in Cartagena, ColombiaPedro Imbeth-Acosta, Víctor Leal-Martínez, Enrique Ramos-Clason, et al.
Future Oncology (London, England)|March 15, 2023
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagusYelena Y Janjigian, Kohei Shitara, Markus Moehler, et al.
Surgical Innovation|July 15, 2025
Gender-Related Discriminations in European Otolaryngology-Head and Neck Surgery: European ReportJerome R Lechien, Abdul-Latif Hamdan, Antonino Maniaci, et al.
Breast Cancer Research and Treatment|June 14, 2021
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancerHope S Rugo, Eduardo J Pennella, Unmesh Gopalakrishnan, et al.
The Lancet. Planetary Health|June 10, 2026
Health integration in national climate adaptation policies from 198 countries: a global policy analysisCatherine Clare Morneau, Dimitri Philippon-Dulac, Xiyun Hu, et al.
American Heart Journal|May 4, 2010
Individual progression of carotid intima media thickness as a surrogate for vascular risk (PROG-IMT): Rationale and design of a meta-analysis projectMatthias W Lorenz, Horst Bickel, Michiel L Bots, et al.
Implementation Science : IS|December 3, 2025
Implementation outcomes of a symptom management intervention in ambulatory oncology practices evaluated using a cluster randomized stepped-wedge trial designJustin D Smith, Katy Bedjeti, Nicola Lancki, et al.
Nature|March 24, 2022
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancerKohei Shitara, Jaffer A Ajani, Markus Moehler, et al.
Clinical Genetics|March 10, 2023
The prevalence and phenotypic range associated with biallelic PKDCC variantsAlistair T Pagnamenta, Rebecca S Belles, Bonnie Anne Salbert, et al.
Pageof 92

Showing results (841-850 of 916) with videos related to

Sort By:
Pageof 92
Molecular Therapy. Methods & Clinical Development|March 4, 2025
Generation and GMP scale-up of human CAR-T cells using non-viral <i>Sleeping Beauty</i> transposons for B cell malignancesBegoña Diez, Cristina Calviño, María Fernández-García, et al.
Frontiers in Medicine|July 21, 2022
Prevalence of Chronic Infection by Hepatitis C Virus in Asymptomatic Population With Risk Factors in Cartagena, ColombiaPedro Imbeth-Acosta, Víctor Leal-Martínez, Enrique Ramos-Clason, et al.
Future Oncology (London, England)|March 15, 2023
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagusYelena Y Janjigian, Kohei Shitara, Markus Moehler, et al.
Surgical Innovation|July 15, 2025
Gender-Related Discriminations in European Otolaryngology-Head and Neck Surgery: European ReportJerome R Lechien, Abdul-Latif Hamdan, Antonino Maniaci, et al.
Breast Cancer Research and Treatment|June 14, 2021
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancerHope S Rugo, Eduardo J Pennella, Unmesh Gopalakrishnan, et al.
The Lancet. Planetary Health|June 10, 2026
Health integration in national climate adaptation policies from 198 countries: a global policy analysisCatherine Clare Morneau, Dimitri Philippon-Dulac, Xiyun Hu, et al.
American Heart Journal|May 4, 2010
Individual progression of carotid intima media thickness as a surrogate for vascular risk (PROG-IMT): Rationale and design of a meta-analysis projectMatthias W Lorenz, Horst Bickel, Michiel L Bots, et al.
Implementation Science : IS|December 3, 2025
Implementation outcomes of a symptom management intervention in ambulatory oncology practices evaluated using a cluster randomized stepped-wedge trial designJustin D Smith, Katy Bedjeti, Nicola Lancki, et al.
Nature|March 24, 2022
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancerKohei Shitara, Jaffer A Ajani, Markus Moehler, et al.
Clinical Genetics|March 10, 2023
The prevalence and phenotypic range associated with biallelic PKDCC variantsAlistair T Pagnamenta, Rebecca S Belles, Bonnie Anne Salbert, et al.
Pageof 92